GLOW Blend Reconstitution Chart (Every Vial Size)

Introduction to Reconstituting Multi-Peptide Blends in Laboratory Settings

In modern biochemical research, multi-component peptide formulations are increasingly utilized to evaluate synergistic cellular mechanisms in vitro. The GLOW research blend typically incorporates three specific peptide sequences in fixed stoichometric ratios: Glycyl-L-histidyl-L-lysine copper complex (GHK-Cu), Body Protection Compound 157 (BPC-157), and Thymosin Beta-4 fragment (TB-500). Because these constituent peptides differ in molecular weight, charge, and secondary structure, maintaining rigorous accuracy during liquid reconstitution is paramount for experimental reproducibility.

When working with high-purity research peptides, calculating accurate microgram-to-microliter metrics requires accounting for total vial mass as well as individual peptide concentrations. Reconstitution involves dissolving the dry, lyophilized cake in a controlled volume of sterile diluent—most commonly Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Normal Saline (0.9% NaCl). This guide outlines the exact concentration output per 0.1 mL (10 IU on a standard 1 mL volumetric syringe) across all standard vial sizes and diluent volumes.

Master GLOW Blend Reconstitution Table

The table below delineates the resulting concentrations for common GLOW blend vial configurations. Standard reference ratios for a 3 mg total vial contain 2,000 mcg (2 mg) GHK-Cu, 500 mcg BPC-157, and 500 mcg TB-500. For scaled research protocols, a 6 mg total vial doubled proportionately contains 4,000 mcg GHK-Cu, 1,000 mcg BPC-157, and 1,000 mcg TB-500, while a 15 mg total vial contains 10,000 mcg GHK-Cu, 2,500 mcg BPC-157, and 2,500 mcg TB-500.

| Vial Mass (Total) | Constituent Breakdown | Diluent Volume added | Total Concentration | GHK-Cu per 0.1 mL | BPC-157 per 0.1 mL | TB-500 per 0.1 mL | |---|---|---|---|---|---|---| | 3.0 mg | 2mg / 0.5mg / 0.5mg | 1.0 mL | 3.0 mg/mL | 200 mcg | 50 mcg | 50 mcg | | 3.0 mg | 2mg / 0.5mg / 0.5mg | 1.5 mL | 2.0 mg/mL | 133.3 mcg | 33.3 mcg | 33.3 mcg | | 3.0 mg | 2mg / 0.5mg / 0.5mg | 2.0 mL | 1.5 mg/mL | 100 mcg | 25 mcg | 25 mcg | | 3.0 mg | 2mg / 0.5mg / 0.5mg | 3.0 mL | 1.0 mg/mL | 66.7 mcg | 16.7 mcg | 16.7 mcg | | 6.0 mg | 4mg / 1.0mg / 1.0mg | 1.0 mL | 6.0 mg/mL | 400 mcg | 100 mcg | 100 mcg | | 6.0 mg | 4mg / 1.0mg / 1.0mg | 2.0 mL | 3.0 mg/mL | 200 mcg | 50 mcg | 50 mcg | | 6.0 mg | 4mg / 1.0mg / 1.0mg | 3.0 mL | 2.0 mg/mL | 133.3 mcg | 33.3 mcg | 33.3 mcg | | 6.0 mg | 4mg / 1.0mg / 1.0mg | 4.0 mL | 1.5 mg/mL | 100 mcg | 25 mcg | 25 mcg | | 15.0 mg | 10mg / 2.5mg / 2.5mg | 2.5 mL | 6.0 mg/mL | 400 mcg | 100 mcg | 100 mcg | | 15.0 mg | 10mg / 2.5mg / 2.5mg | 3.0 mL | 5.0 mg/mL | 333.3 mcg | 83.3 mcg | 83.3 mcg | | 15.0 mg | 10mg / 2.5mg / 2.5mg | 5.0 mL | 3.0 mg/mL | 200 mcg | 50 mcg | 50 mcg | | 15.0 mg | 10mg / 2.5mg / 2.5mg | 10.0 mL | 1.5 mg/mL | 100 mcg | 25 mcg | 25 mcg |

Data presented above assumes complete dissolution in neutral pH diluent and assumes negligible volume displacement by the solid lyophilized cake. Researchers requiring custom volumetric ratios can utilize our interactive reconstitution calculator for automated solution metrics.

Mathematical Formulas for Multi-Peptide Solution Calculations

To calculate the concentration of any individual component within a reconstituted blend, researchers must evaluate each sequence independently relative to total liquid volume. The fundamental formulas governing these calculations are defined as follows:

1. Total Solution Concentration (C_total) = Total Mass of All Peptides (mg) / Reconstitution Volume (mL) 2. Individual Peptide Concentration (C_individual) = Mass of Specific Peptide (mcg or mg) / Reconstitution Volume (mL) 3. Aliquot Delivery per Volumetric Unit (D_aliquot) = C_individual × Target Sampling Volume (mL)

Because laboratory pipettes and U-100 volumetric syringes measure sampling in microliters (µL) or international units (where 100 IU = 1.0 mL, meaning 1 IU = 0.01 mL), converting total mass to micrograms (1 mg = 1,000 mcg) simplifies working equations. Applying these standardized formulas eliminates guesswork during cell culture dosing or analytical assays.

Worked Example 1: Reconstitution of a Standard 3 mg GLOW Blend Vial

Consider a scenario where a laboratory technician needs to prepare a standard vial of GLOW Blend 2mg GHK-Cu / 500mcg BPC-157 / 500mcg TB-500 using 2.0 mL of Bacteriostatic Water.

Step 1: Determine constituent masses. - GHK-Cu = 2,000 mcg - BPC-157 = 500 mcg - TB-500 = 500 mcg - Total Peptide Mass = 3,000 mcg (3.0 mg)

Step 2: Calculate individual concentrations per mL. - Concentration GHK-Cu = 2,000 mcg / 2.0 mL = 1,000 mcg/mL - Concentration BPC-157 = 500 mcg / 2.0 mL = 250 mcg/mL - Concentration TB-500 = 500 mcg / 2.0 mL = 250 mcg/mL

Step 3: Calculate the yield per 0.1 mL (10 IU on a standard syringe). - GHK-Cu = 1,000 mcg/mL × 0.1 mL = 100 mcg - BPC-157 = 250 mcg/mL × 0.1 mL = 25 mcg - TB-500 = 250 mcg/mL × 0.1 mL = 25 mcg

Thus, drawing 0.1 mL of solution delivers exactly 100 mcg of GHK-Cu, 25 mcg of BPC-157, and 25 mcg of TB-500 to the experimental assay.

Worked Example 2: High-Volume Dilution for High-Capacity Vials

In scaled preclinical trials, laboratory settings may utilize a high-capacity 15 mg GLOW vial containing 10,000 mcg GHK-Cu, 2,500 mcg BPC-157, and 2,500 mcg TB-500. If the protocol demands a lower viscosity solution, the investigator adds 5.0 mL of diluent.

Step 1: Calculate total and individual peptide concentrations. - Concentration GHK-Cu = 10,000 mcg / 5.0 mL = 2,000 mcg/mL - Concentration BPC-157 = 2,500 mcg / 5.0 mL = 500 mcg/mL - Concentration TB-500 = 2,500 mcg / 5.0 mL = 500 mcg/mL

Step 2: Determine sampling volume yield for a 0.05 mL (5 IU) micro-aliquot. - GHK-Cu yield = 2,000 mcg/mL × 0.05 mL = 100 mcg - BPC-157 yield = 500 mcg/mL × 0.05 mL = 25 mcg - TB-500 yield = 500 mcg/mL × 0.05 mL = 25 mcg

This higher total vial mass allows research teams to prepare multiple controlled micro-aliquots without exceeding volumetric pipette limits in high-throughput screening assays.

Diluent Selection: Bacteriostatic Water vs. Sterile 0.9% Sodium Chloride

Choosing the appropriate solvent directly impacts reconstituted solution shelf life, peptide stability, and solubility profile. The two primary diluents used in laboratory settings are Bacteriostatic Water for Injection (0.9% benzyl alcohol) and Sterile 0.9% Sodium Chloride (Normal Saline).

Bacteriostatic Water is the preferred choice for multi-use research vials intended for storage over multiple days or weeks. The inclusion of 0.9% benzyl alcohol acts as a bacteriostatic preservative, suppressing microbial growth in refrigerated conditions (2°C to 8°C) for up to 28 days. Conversely, unpreserved Sterile Normal Saline or pure Sterile Water for Injection lacks antimicrobial agents; vials reconstituted with non-preserved solvents must be utilized immediately or aliquoted into single-use microcentrifuge tubes and frozen at -20°C to prevent degradation and bacterial proliferation.

Aseptic Reconstitution Protocols and Dissolution Dynamics

Reconstitution of lyophilized peptides must occur within a certified laminar flow hood or cleanroom environment using strict aseptic techniques to maintain purity and prevent contamination:

1. Disinfect the rubber septum of the GLOW blend vial using a 70% isopropyl alcohol wipe and allow it to air-dry completely. 2. Draw the exact required volume of diluent (e.g., 2.0 mL) using a sterile, single-use syringe fitted with a 21G to 25G needle. 3. Insert the needle through the center of the rubber stopper at a 45-degree angle, then straighten to prevent core displacement of the stopper material. 4. Direct the stream of diluent down the glass inner wall of the vial rather than shooting it directly onto the lyophilized cake. Forceful direct impact can disrupt delicate peptide tertiary structures. 5. Allow the diluent to passively saturate the lyophilized powder. Gentle rotational swirling may be applied. Never shake the vial violently, as mechanical shear stress can induce peptide denaturation or foam formation.

Comparative Analysis: Reconstituting Multi-Peptide Blends vs. Monomers

When managing individual research compounds such as standalone GHK-Cu peptide, BPC-157 peptide, or TB-500 peptide, reconstituting individual powders involves single-variable calculations. However, pre-formulated multi-peptide blends like GLOW offer significant advantages in standardized analytical models.

Pre-blended lyophilized cakes eliminate intra-assay pipetting errors that occur when mixing three separate monomer solutions into a culture well. Furthermore, because GHK-Cu contains a copper chelating moiety, its presence imparts a characteristic distinct light-blue hue to the solution once fully dissolved. Observing a clear, pale-blue particulate-free solution confirms complete dissolution across all three components in the blend.

Storage, Stability, and Handling Requirements

Lyophilized GLOW blend vials are stable at controlled room temperature for short transit periods, but long-term storage of dry powder requires refrigeration at -20°C. Once reconstituted with Bacteriostatic Water, the vial must be stored continuously between 2°C and 8°C (36°F to 46°F) and shielded from light exposure.

Preclinical studies suggest that repeated freeze-thaw cycles of reconstituted liquid peptide solutions cause physical degradation via ice-crystal formation and aggregation. If long-term storage of reconstituted material is necessary, research labs should instantly divide the solution into single-use working aliquots in sterile polypropylene tubes and freeze at -20°C or -80°C until assay deployment.

Quality Assurance, Purity, and COA Verification at PX1 Research

PX1 Research enforces strict quality control standards across every manufactured batch. Every lot of GLOW blend undergoes rigorous High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) testing to verify chemical identity, sequence integrity, and exact mass ratios. Every batch is certified to exceed 99% purity.

Additionally, our products undergo bacterial endotoxin testing (LAL assay) to guarantee safe inclusion in sensitive cell culture and in vitro models. Researchers can review batch-specific test results at any time via our public PX1 COA database. For large-scale university laboratories or institutional purchasing departments requiring bulk supply, expanded documentation and specialized tier pricing are available through our wholesale program. To explore broader technical literature on peptide stability and analytical methodology, visit the PX1 research library.